Maternal and Neonatal Outcomes in Pregnancies Complicated by Systemic Lupus Erythematosus: A Population-Based Study

Journal of Obstetrics and Gynaecology Canada

Volumn 35, Issue 4, 2013, Pages 323-328

  Nili, Firouzeh ^a   McLeod, Lynne ^b   O'Connell, Colleen ^c   Sutton, Evelyn ^b   McMillan, Douglas ^c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b DALHOUSIE UNIVERSITY   (Canada)

^c DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Competing Interests: None declared; Newborn; Outcome; Pregnancy; Systemic lupus erythematosus

Indexed keywords

ADULT; ARTICLE; ASSISTED VENTILATION; BIRTH WEIGHT; BLOOD TRANSFUSION; BRAIN HEMORRHAGE; CESAREAN SECTION; COHORT ANALYSIS; CONGENITAL HEART BLOCK; CONTROLLED STUDY; DATA BASE; DISEASE SEVERITY; FEMALE; FEVER; GESTATIONAL AGE; HUMAN; LIVE BIRTH; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MALE; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; NEWBORN DEATH; NOVA SCOTIA; PATENT DUCTUS ARTERIOSUS; POPULATION RESEARCH; POSTPARTUM HEMORRHAGE; PREECLAMPSIA; PREGNANCY OUTCOME; RESUSCITATION; RETROLENTAL FIBROPLASIA; RETROSPECTIVE STUDY; SMALL FOR DATE INFANT; SYSTEMIC LUPUS ERYTHEMATOSUS; CANADA; HEART BLOCK; OUTCOME; PATHOPHYSIOLOGY; PREGNANCY; PREGNANCY COMPLICATION; PREMATURITY; STATISTICS;

NEWBORN; OUTCOME; PREGNANCY; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; BIRTH WEIGHT; BLOOD TRANSFUSION; BRONCHOPULMONARY DYSPLASIA; CESAREAN SECTION; DUCTUS ARTERIOSUS, PATENT; FEMALE; GESTATIONAL AGE; HEART BLOCK; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INFANT, SMALL FOR GESTATIONAL AGE; LUPUS ERYTHEMATOSUS, SYSTEMIC; NOVA SCOTIA; POSTPARTUM HEMORRHAGE; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; RESPIRATORY DISTRESS SYNDROME, NEWBORN; RETINOPATHY OF PREMATURITY;

MLCS; MLOWN;

EID: 84879536969     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(15)30959-2     Document Type: Article

References (21)

1. Kotzin B.L. Systemic lupus erythematosus. Cell 1996, 85:6-303.
2. Silver R.M., Branch D.W. Autoimmune disease in pregnancy. Clin Perinatol 1997, 24:291-320.
3. Clowse M.E. Lupus activity in pregnancy. Rheum Dis Clin North Am 2007, 33:237-252.
4. Molad Y., Borkowski T., Monselise A., Ben-Haroush A., Sulkes J., Hod M., et al. Maternal and fetal outcome of lupus pregnancy: a prospective study of 29 pregnancies. Lupus 2005, 14:145-151.
5. Kim S.Y., Lee J.H. Prognosis of neonates in pregnant women with SLE. Yonsei Med J 2008, 49:515-520.
6. Motta M., Ticani A., Lojacono A., Faden D., Gorla R., Airo P., et al. Neonataloutcome in patients with rheumatic disease. Lupus 2004, 13:S718-S723.
7. Boros C.A., Spence D., Blaser S., Silverman E.D. Hydrocephalus and macrocephalus: new manifestations of neonatal lupus erythematosus. Arthritis Rheum 2007, 57:6-261.
8. Lee L.A., Sokol R.J., Buyon J.P. Hepatobiliary disease in neonatal lupus: prevalence and clinical characteristics in cases enrolled in a national registry. Pediatrics 2002, 109:1-4.
9. Joseph K.S., Fahey J., Dendukur N., Allen V.M., O'Campo P., Dodds L., et al. Recent changes in maternal characteristics by socioeconomic status. J Obstet Gynaecol Can 2009, 31:422-433.
10. Statistics Canada Profile of census division and subdivision in Nova Scotia. Catalogue no.95-547-XP8 2006, 10-14.
11. Yasmeen S., Wilkins E., Field N., Sheikh R., Gilbert W. Pregnancy outcomes in women with SLE. J Matern Fetal Med 2001, 10:91-96.
12. Buyon J., Kalunian K., Ramsey-Goldman R., Petri M.A., Lockshin M.D., Ruiz-Iraztorza G., et al. Assessing disease activity in SLE patients during pregnancy. Lupus 1999, 8:677-684.
13. Mousa H.A., Alfirevic Z. Treatment for primary postpartum hemorrhage. Cochrane Libr 2007 2010, 4. Available at:, Accessed January 21. http://www.thecochranelibrary.com.
14. Cunningham F.G., Leveno K.J., Bloom S.L., Hault J.C., Rouse D.J., Spongy C.Y. Obstetrical hemorrhage. Williams Obstetrics, 23rd ed 2010, 759-760. McGraw-Hill, NewYork. F.G. Cunningham, K.J. Leveno, S.L. Bloom, J.C. Hault, D.J. Rouse, S. CY (Eds.).
15. Sosa C.G., Alathabe F., Belizan J.M., Bueken P. Risk factors for postpartum hemorrhage in vaginal deliveries in a Latin-American population. Obstet Gynecol 2009, 113:9-1313.
16. Drews R.E. Critical issues in hematology: anemia, thrombocytopenia, coagulopathy, and blood product transfusions in critically ill patients. Clin Chest Med 2003, 24:607-622.
17. Miyakis S., Lockshin M.D., Atsumi T., Branch D.W., Brey R.L., Cervera R., et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome. J Thromb Haemost 2006, 4:295-306.
18. Maharaj D. Puerperal pyrexia: a review. Part II. Obstet Gynecol Surv 2007, 62:6-400.
19. Carmona F., Font J., Cevera R., Munoz F., Cararach V., Balasch J. Obstetrical outcome of pregnancy in patients with SLE. A study of 60 cases. Eur J Obstet Gynecol Reprod Biol 1999, 83:137-142.
20. Cowhock F.S., Reece E.A., Balaban D., Branch D.W., Plouffe L. Repeated fetal losses associated with antiphospholipid antibodies: a collaborative trial comparing prednisone with low-dose heparin treatment. Am J Obstet Gynecol 1992, 166:1398-1429.
21. Martin R.J., Fanaroff A.A., Walsh M.C. Fetal effects of autoimmune disease, 8th ed 2006, 371. Mosby, St. Louis, MO. I. Blickstein, S. Friedman (Eds.).